Screening and diagnosis

Classification and risk stratification

Perioperative care

Quality improvement

Patient education

Nonpharmacologic interventions

Therapeutic procedures

Respiratory support

Follow-up and surveillance

Specific circumstances

Preventative measures

Medical management

Surgical interventions

Inpatient care

Diagnostic procedures

Diagnostic investigations

Insufficient evidence to make a recommendation.

Strongly favor this test or intervention.

This Killip classification tool is used to assess the severity of a patient's heart failure by examining clinical signs and estimating the risk of death within 30 days. By selecting one of four possible descriptions of a patient's clinical presentation, you can quickly determine the associated Killip class and its mortality risk.

- If the patient exhibits "No clinical signs of cardiac decompensation," they are classified as Killip I, which correlates with a 2.8% risk of 30-day mortality. This situation represents the lowest risk and indicates a relatively stable cardiac status without signs of acute stress.

- Selecting "S3 gallop, basal rales on auscultation and venous hypertension" corresponds to Killip II, suggesting moderate impairment with an 8.8% risk of dying within 30 days. The presence of these specific symptoms indicates some level of heart failure progression.

- A classification of "Acute pulmonary edema" identifies the patient as Killip III, with a 14.4% mortality risk over 30 days. This reflects a severe level of heart failure, as acute pulmonary edema implies significant fluid build-up in the lungs.

- In the most critical scenario, "Cardiogenic shock," the patient is categorized as Killip IV, also corresponding to a 14.4% 30-day mortality risk. Cardiogenic shock involves critically compromised heart function, leading to inadequate circulation and oxygenation throughout the body.

Choosing the appropriate classification enables health professionals to rapidly assess patient risk and ensure appropriate treatment is prioritized, aligning clinical assessment with expected outcomes.

The Killip Classification is a system used in patients with myocardial infarction, specifically to stratify risk and predict mortality. It was named after Dr. Kimball Killip, who first introduced it in 1967. The classification is based on physical examination findings and is used to estimate the severity of heart failure in patients who have had a heart attack. 

The Killip Classification consists of four classes:

- Killip Class I: No clinical signs of heart failure.
- Killip Class II: Rales or crackles in the lungs, an S3, and elevated jugular venous pressure.
- Killip Class III: Acute pulmonary edema.
- Killip Class IV: Cardiogenic shock or hypotension, and evidence of peripheral vasoconstriction (oliguria, cyanosis, and sweating).

The higher the Killip class, the higher the risk of mortality within the first 30 days of the myocardial infarction. This classification helps clinicians to identify high-risk patients who may benefit from more aggressive treatment. 

There are no specific exclusion criteria for the use of the Killip Classification, but it is less applicable in patients without myocardial infarction or in those with heart failure due to other causes.

Killip classification for heart failure

The calculator categorizes the severity of heart failure using the New York Heart Association (NYHA) functional classification system. It does this by analyzing a patient's reported physical abilities related to cardiac disease and matches them to one of the four NYHA classes.

Here's the breakdown of each class:

- Class I involves patients who have cardiac disease but do not experience any limitations in physical activity. Regular activities do not cause undue fatigue, palpitation, or shortness of breath.
  
- Class II fits patients who have a slight limitation in physical activity due to cardiac disease. They feel comfortable when at rest, but ordinary physical activities might lead to fatigue, palpitation, or breathlessness.
  
- Class III describes patients with a marked limitation in physical activity. These individuals are comfortable when resting, but even less than ordinary activities cause fatigue, palpitations, breathlessness, or chest pain.
  
- Class IV covers patients who cannot engage in any physical activity without experiencing discomfort. They exhibit symptoms of heart failure even when at rest, and any physical activity worsens these symptoms.

To determine the appropriate class for a patient, the calculator compares the user’s description of their physical ability with these four established patterns. Each condition is linked specifically to one of the NYHA classes, providing a clear pathway from symptom description to classification. For example, if a patient’s physical condition matches the criteria for Class I, then the result is "Class I." This comparison method efficiently identifies the level of heart failure severity based on self-reported abilities and symptoms.

The NYHA functional classification for heart failure, or New York Heart Association Functional Classification, is a scoring system used to quantify the severity of symptoms in patients with heart failure. This classification system is applicable to patients diagnosed with heart failure and is used to assess their functional capacity and limitations during physical activity. 

The NYHA classification is divided into four classes: Class I (no symptoms and no limitation in ordinary physical activity), Class II (mild symptoms and slight limitation during ordinary activity), Class III (marked limitation in activity due to symptoms, even during less-than-ordinary activity), and Class IV (severe limitations, experiences symptoms even while at rest).

The clinical utility of this calculator is to guide treatment decisions, assess prognosis, and evaluate the effectiveness of therapeutic interventions in patients with heart failure. It is also commonly used in clinical trials to stratify patients and measure outcomes. 

There are no specific exclusion criteria for its use, but it is subjective and relies on patient self-report, so it may not be as accurate in patients with cognitive impairment or communication difficulties.

NYHA functional classification for heart failure

The assessment of diastolic function is a method that evaluates four critical echocardiographic parameters, which aid in understanding the state of a patient's diastolic function in the absence of left ventricular structural pathology. Here's how this assessment operates:

- It examines whether the patient's septal e' velocity is less than 7 cm/s or the lateral e' velocity falls below 10 cm/s.
- It checks if the average E/e' ratio exceeds 14.
- It assesses if the peak tricuspid regurgitation (TR) velocity is greater than 2.8 m/s.
- Lastly, it considers whether the left atrial volume index surpasses 34 mL/m².

For each of these parameters:

- A 'true' response indicates the clinical threshold is met, contributing a score of 1 point to the assessment.
- The total score, therefore, ranges from 0 to 4, depending on the number of criteria met.

The total score results in an interpretation which offers insights into the patient's diastolic function:

- A score of 0 or 1 suggests normal diastolic function, indicating no diastolic dysfunction.
- A score of 2 implies an indeterminate state, where the results are ambiguous regarding the presence of diastolic dysfunction.
- Scores of 3 or 4 denote abnormal diastolic function, implying significant diastolic complications.

This concise framework aids clinicians in identifying diastolic dysfunction and determining subsequent clinical actions.

The calculator in question is the Assessment of Diastolic Function (no LV structural pathology). This calculator is used in the specific patient population of individuals suspected of having diastolic dysfunction but who do not have any structural pathology of the left ventricle (LV). 

The clinical utility of this calculator is to assess the diastolic function of the heart, which is the phase of the cardiac cycle when the heart relaxes and fills with blood. This is crucial in diagnosing conditions such as heart failure with preserved ejection fraction (HFpEF), also known as diastolic heart failure. 

The calculator uses parameters such as mitral inflow velocities, tissue Doppler imaging, and left atrial size to determine the likelihood of diastolic dysfunction. 

Exclusion criteria for its use would include patients with significant left ventricular structural abnormalities, such as hypertrophy or dilation, as these could affect the diastolic function independently. Additionally, it may not be suitable for patients with certain arrhythmias or severe valvular diseases, as these conditions can also influence the parameters used in the calculator.

Assessment of diastolic function (no LV structural pathology)

The assessment tool for diastolic dysfunction evaluates the severity by considering three key heart measurements. These measurements, derived from echocardiographic data, are examined against defined thresholds to determine their significance. Each measurement is represented as a boolean value indicating whether it exceeds a specified threshold.

Here’s how the assessment works:

1. **Inputs**  
   - **Average E/e' ratio > 14**: This indicates whether the average ratio of early mitral inflow velocity to early diastolic mitral annular velocity exceeds 14. A higher ratio suggests increased left atrial pressure and diastolic dysfunction.
   - **Peak TR velocity > 2.8 m/s**: Tricuspid regurgitation (TR) peak velocity assesses right heart pressures. Exceeding 2.8 m/s may indicate pulmonary hypertension associated with diastolic dysfunction.
   - **Left atrial volume index > 34 mL/m²**: A large left atrial volume index suggests chronic pressure overload and can be a sign of diastolic dysfunction.

2. **Scoring System**  
   - Each of the three input measurements, if exceeding its respective threshold, contributes a score of 1. The possible scores range from 0 to 3, where:
     - The average E/e' ratio condition contributes 1 point if true.
     - The peak TR velocity condition contributes 1 point if true.
     - The left atrial volume index condition contributes 1 point if true.

3. **Interpretation Rules**  
   - **Score 0 or 1**: Interpreted as Grade 1 diastolic dysfunction, suggesting mild dysfunction with only one or no parameters exceeding their thresholds.
   - **Score 2 or 3**: Indicates Grade 2 diastolic dysfunction, reflecting more significant dysfunction where two or more measurements exceed their thresholds.

The outcome is a structured result that not only delivers a numerical score reflecting the assessment but also provides an interpretation of the diastolic dysfunction severity based on the key heart function measurements involved.

| Measurement Evaluated                   | Score Contribution | Threshold for "True"           |
|-----------------------------------------|-------------------|--------------------------------|
| Average E/e' ratio > 14                 | 1                 | Ratio greater than 14          |
| Peak TR velocity > 2.8 m/s              | 1                 | Velocity greater than 2.8 m/s  |
| Left atrial volume index > 34 mL/m²     | 1                 | Volume index greater than 34   |

The calculator in question is the Assessment of Diastolic Dysfunction Severity (with Left Ventricular Structural Pathology). This clinical calculator is used primarily in the field of cardiology, specifically for patients who have been diagnosed with diastolic heart failure or are suspected of having this condition. 

The clinical utility of this calculator is to assess the severity of diastolic dysfunction in patients with structural pathology of the left ventricle. It helps in stratifying the risk and guiding the management of patients with diastolic heart failure. The calculator uses parameters such as left atrial volume index, tricuspid regurgitation velocity, and average E/e' ratio to determine the severity of diastolic dysfunction.

Exclusion criteria for its use would include patients without structural pathology of the left ventricle, those with systolic heart failure, and patients with other types of heart diseases that could affect the parameters used in the calculator. It's also important to note that this calculator should be used in conjunction with other clinical assessments and not as a standalone diagnostic tool.

Assessment of diastolic dysfunction severity (with LV structural pathology)

The Revised Cardiac Risk Index (RCRI) calculator assesses perioperative cardiac risks by taking into account six specific risk factors associated with the patient. Each factor corresponds to a condition or characteristic, and if the patient exhibits that factor, it scores 1 point. The total score, ranging from 0 to 6, represents the overall cardiac risk.

The six risk factors analyzed are as follows:
1. High-risk surgery (intraperitoneal, intrathoracic, or suprainguinal vascular surgery)
2. History of ischemic heart disease (including myocardial infarction, positive exercise test, ECG with pathological Q waves, current ischemic chest pain, or use of nitrate)
3. History of congestive heart failure (with manifestations such as pulmonary edema, bilateral rales, S3 gallop, paroxysmal nocturnal dyspnea, or pulmonary vascular redistribution on chest X-ray)
4. History of cerebrovascular disease (transient ischemic attack or stroke)
5. Use of insulin for diabetes
6. Preoperative creatinine level above 2 mg/dL or 178 mcmol/L

A boolean input for each risk factor determines its presence, scoring 1 point if true and 0 if false. The sum of these points results in the total score.

Based on the computed score, the calculator provides an interpretation reflecting the patient's estimated risk of experiencing a major cardiac event (MI, cardiac arrest, or mortality) within 30 days post-surgery:

- Score of 0: Risk is 3.9%
- Score of 1: Risk is 6.0%
- Score of 2: Risk is 10.1%
- Score of 3 or more: Risk is 15.0%

The calculator simplifies the complex assessment of cardiac perioperative risks into a quantifiable measure, guiding healthcare providers in evaluating and mitigating potential cardiac complications in surgical patients. Here is the summary of how scores are interpreted in relation to risk percentages:

| Score | Risk Interpretation                                  |
|-------|------------------------------------------------------|
| 0     | Risk of 30-day MI, cardiac arrest, or mortality is 3.9% |
| 1     | Risk of 30-day MI, cardiac arrest, or mortality is 6.0% |
| 2     | Risk of 30-day MI, cardiac arrest, or mortality is 10.1% |
| 3 or more | Risk of 30-day MI, cardiac arrest, or mortality is 15.0% |

This structured approach helps balance the decision-making process by providing a clear estimate of cardiac risk based on specific, patient-related factors.

The Revised Cardiac Risk Index (RCRI) is a clinical calculator used to estimate the risk of cardiac complications during the perioperative period in patients undergoing non-cardiac surgery. It is particularly useful for stratifying patients into different risk categories based on six identified risk factors: high-risk surgery, history of ischemic heart disease, history of congestive heart failure, history of cerebrovascular disease, insulin therapy for diabetes, and preoperative serum creatinine >2.0 mg/dL. 

The RCRI is not applicable to patients undergoing cardiac surgery, as it was specifically designed for non-cardiac surgical procedures. It also may not be as accurate in populations not represented in the original study, such as those with less common comorbidities or undergoing less common surgical procedures.

Heart failure

Background

Overview

Guidelines

Key sources